A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

Published:1993-12-01 Issue:11 Volume:72 Page:3196-3201
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Colleoni Marco,Buzzoni Roberto,Bajetta Emilio,Bochicchio A. Maria,Bartoli Cesare,Audisio Riccardo,Bonfanti Giuliano,Nolè Franco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. , . Cancer of the hepatobiliary system. In: , , editors. Cancer: principles and practice of oncology. 2nd ed. Philadelphia: JB Lippincott, 1985; 741–53.

2. Carcinoma epatico. Catania: Cyanamid, 1989: 32–6.

3. Clinical trials in primary hepatocellular carcinoma: current status and future directions

4. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study

5. A phase II trial of tamoxifen in hepatocellular carcinoma

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes;Journal of Controlled Release;2017-03

2. Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma;Colloids and Surfaces B: Biointerfaces;2017-03

3. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma;Mediators of Inflammation;2017

4. Medical Therapy of HCC;Hepatocellular Carcinoma;2016

5. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?;Cancer;2015-11-05